Alex Z. Fu MS, PhD

Dr. Fu is a health services researcher and health economist, currently an Associate Professor at Georgetown University Medical Center. He is also a Group Leader at Janssen Pharmaceutical Companies of Johnson & Johnson. Prior to joining the faculty at Georgetown University in 2012, he was an assistant and then an associate faculty member at Cleveland Clinic Department of Quantitative Health Sciences, and Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He received his Ph.D. degree in Pharmaceutical Outcomes and Policy from the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy. Dr. Fu’s primary research interests are comparative effectiveness and cost-effectiveness research, especially by using large observational datasets. The core focus of his work is to investigate which treatments work best, for whom, under what circumstances, and with the greatest cost-effectiveness. The results can assist consumers, clinicians, purchasers, and policymakers to make more informed decisions about health care at both individual and population levels. He enjoys applying as well as improving cutting-edge research methodologies in health outcomes research with experience in many chronic disease conditions. Dr. Fu is an investigator on a list of NIH-supported studies. He has been a member of the Agency for Healthcare Research and Quality (AHRQ) study section and has been on various scientific committees of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) since 2005. He currently serves as a Co-Editor for the ISPOR official journal Value in Health and on the editorial board for the Journal of Medical Economics. He has published more than 70 peer-reviewed articles, commentaries, and book chapters, and his articles appear in scientific journals such as Journal of Clinical Oncology, Circulation, Diabetes Care, Journal of Health Economics, and Medical Decision Making.